The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADMA BIOLOGICS INC | COM | 000899104 | 9,499,700 | 2,870,000 | SH | SOLE | 2,870,000 | 0 | 0 | |||
AKOYA BIOSCIENCES INC | COM | 00974H104 | 4,090,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
ALPHATEC HLDGS INC | COM NEW | 02081G201 | 4,212,000 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | |||
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 5,427,900 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | |||
ARCELLX INC | COMMON STOCK | 03940C100 | 4,621,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 17,916,270 | 1,347,088 | SH | SOLE | 1,347,088 | 0 | 0 | |||
AULT DISRUPTIVE TECHS CORP | COM | 05150A104 | 1,570,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 4,580,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 8,150,400 | 1,132,000 | SH | SOLE | 1,132,000 | 0 | 0 | |||
BIOHAVEN LTD | COM | G1110E107 | 3,551,600 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | |||
BIOLINERX LTD | SPONSORED ADS | 09071M205 | 2,020,916 | 2,279,657 | SH | SOLE | 2,279,657 | 0 | 0 | |||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 2,569,900 | 155,000 | SH | SOLE | 155,000 | 0 | 0 | |||
BRUUSH ORAL CARE INC | *W EXP 08/03/202 | 11750K120 | 43,269 | 360,579 | SH | SOLE | 360,579 | 0 | 0 | |||
CEA INDUSTRIES INC | *W EXP 02/11/202 | 86887P119 | 19,825 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
CHAVANT CAPITAL ACQUISITN CO | *W EXP 99/99/999 | G2058L111 | 4,710 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
CHICKEN SOUP FOR THE SOUL EN | CL A | 16842Q100 | 424,328 | 212,164 | SH | SOLE | 212,164 | 0 | 0 | |||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 7,060,750 | 305,000 | SH | SOLE | 305,000 | 0 | 0 | |||
CINGULATE INC | *W EXP 12/10/202 | 17248W113 | 46,197 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | |||
COLISEUM ACQUISITION CORP | CLASS A ORD SHS | G2263T123 | 872,100 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | |||
COLISEUM ACQUISITION CORP | *W EXP 08/22/202 | G2263T107 | 4,108 | 28,333 | SH | SOLE | 28,333 | 0 | 0 | |||
COLOMBIER ACQUISITION CORP | *W EXP 99/99/999 | 19533H116 | 3,605 | 16,666 | SH | SOLE | 16,666 | 0 | 0 | |||
COLOMBIER ACQUISITION CORP | CL A | 19533H108 | 506,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 1,606,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
CTI BIOPHARMA CORP | COM | 12648L601 | 3,570,000 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | |||
CVRX INC | COM | 126638105 | 1,910,600 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | |||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 5,406,400 | 620,000 | SH | SOLE | 620,000 | 0 | 0 | |||
DIGITAL HEALTH ACQUISITION C | *W EXP 11/02/202 | 253893119 | 12,750 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
DIRECT DIGITAL HOLDINGS INC | *W EXP 02/15/202 | 25461T113 | 135,000 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | |||
DOUBLEDOWN INTERACTIVE CO LT | ADS | 25862B109 | 485,790 | 60,876 | SH | SOLE | 60,876 | 0 | 0 | |||
DYNE THERAPEUTICS INC | COM | 26818M108 | 1,785,600 | 155,000 | SH | SOLE | 155,000 | 0 | 0 | |||
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 4,820 | 133,333 | SH | SOLE | 133,333 | 0 | 0 | |||
FAT BRANDS INC | *W EXP 07/16/202 | 30258N121 | 896,650 | 227,000 | SH | SOLE | 227,000 | 0 | 0 | |||
GENEDX HOLDINGS CORP | COM CL A | 81663L101 | 1,674,620 | 4,588,000 | SH | SOLE | 4,588,000 | 0 | 0 | |||
GLAUKOS CORP | COM | 377322102 | 4,559,100 | 91,000 | SH | SOLE | 91,000 | 0 | 0 | |||
GSR II METEORA ACQUISITN COR | *W EXP 02/24/202 | 36263W121 | 2,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
GSR II METEORA ACQUISITN COR | CLASS A COM | 36263W105 | 517,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
HARBOR CUSTOM DEVELOPMENT IN | *W EXP 05/09/202 | 41150T116 | 14,460 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | |||
HARBOR CUSTOM DEVELOPMENT IN | *W EXP 10/07/202 | 41150T124 | 32,435 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | |||
HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 979,500 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | |||
ILLUMINA INC | COM | 452327109 | 2,092,950 | 9,000 | SH | SOLE | 9,000 | 0 | 0 | |||
INNOVATIVE EYEWEAR INC | *W EXP 08/16/202 | 45791D117 | 44,768 | 122,400 | SH | SOLE | 122,400 | 0 | 0 | |||
INSPIRE MED SYS INC | COM | 457730109 | 2,925,875 | 12,500 | SH | SOLE | 12,500 | 0 | 0 | |||
INVITAE CORP | COM | 46185L103 | 552,420 | 409,200 | SH | SOLE | 409,200 | 0 | 0 | |||
IVERIC BIO INC | COM | 46583P102 | 3,162,900 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | |||
JEFFS BRANDS LTD | *W EXP 08/26/202 | M61472110 | 106,058 | 980,770 | SH | SOLE | 980,770 | 0 | 0 | |||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 1,967,488 | 505,781 | SH | SOLE | 505,781 | 0 | 0 | |||
KORU MEDICAL SYSTEMS INC | COM | 759910102 | 2,890,708 | 685,002 | SH | SOLE | 685,002 | 0 | 0 | |||
LIGHTNING EMOTORS INC | *W EXP 05/18/202 | 53228T119 | 16,630 | 652,173 | SH | SOLE | 652,173 | 0 | 0 | |||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 1,578,127 | 228,714 | SH | SOLE | 228,714 | 0 | 0 | |||
MERSANA THERAPEUTICS INC | CALL | 59045L906 | 3,082,911 | 750,100 | SH | Call | SOLE | 750,100 | 0 | 0 | ||
MIMEDX GROUP INC | COM | 602496101 | 2,550,680 | 748,000 | SH | SOLE | 748,000 | 0 | 0 | |||
MURPHY CANYON ACQUISITION CO | *W EXP 01/25/202 | 626642110 | 9,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
MYRIAD GENETICS INC | COM | 62855J104 | 4,181,400 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | |||
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 2,237,321 | 225,992 | SH | SOLE | 225,992 | 0 | 0 | |||
NEOGENOMICS INC | COM NEW | 64049M209 | 4,178,400 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | |||
NEXALIN TECHNOLOGY INC | *W EXP 09/15/202 | 65345B110 | 9,975 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | |||
NEXGEL INC | *W EXP 12/01/202 | 65344E115 | 34,875 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | |||
NLS PHARMACEUTICS LTD | *W EXP 02/02/202 | H57830111 | 30,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
NOVOCURE LTD | CALL | G6674U908 | 9,712,610 | 161,500 | SH | Call | SOLE | 161,500 | 0 | 0 | ||
ONFOLIO HOLDINGS INC | *W EXP 01/02/202 | 68277K124 | 28,090 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
OPY ACQUISITION CORP I | *W EXP 09/22/202 | 671005114 | 7,665 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
OPY ACQUISITION CORP I | COM CL A | 671005106 | 512,750 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 2,061,240 | 178,000 | SH | SOLE | 178,000 | 0 | 0 | |||
PANBELA THERAPEUTICS INC | COM NEW | 69833W206 | 148,280 | 335,324 | SH | SOLE | 335,324 | 0 | 0 | |||
PENUMBRA INC | COM | 70975L107 | 4,459,040 | 16,000 | SH | SOLE | 16,000 | 0 | 0 | |||
PEPPERLIME HEALTH ACQUSTN CO | CLASS A ORD SHS | G70021103 | 1,018,500 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
PEPPERLIME HEALTH ACQUSTN CO | *W EXP 10/01/202 | G70021111 | 34,949 | 367,500 | SH | SOLE | 367,500 | 0 | 0 | |||
POLISHED COM INC | *W EXP 06/02/202 | 28252C117 | 603,668 | 6,103,824 | SH | SOLE | 6,103,824 | 0 | 0 | |||
POLISHED COM INC | COM | 28252C109 | 299,603 | 576,048 | SH | SOLE | 576,048 | 0 | 0 | |||
PROSOMNUS INC | *W EXP 04/20/202 | 50535E116 | 23,700 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 3,182,200 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | |||
RELATIVITY ACQUISITION CORP | *W EXP 12/15/202 | 75944B114 | 0 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
REPLIMUNE GROUP INC | COM | 76029N106 | 2,613,680 | 148,000 | SH | SOLE | 148,000 | 0 | 0 | |||
RESMED INC | COM | 761152107 | 3,722,830 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | |||
REVELATION BIOSCIENCES INC | COM NEW | 76135L309 | 48,357 | 37,198 | SH | SOLE | 37,198 | 0 | 0 | |||
SELINA HOSPITALITY PLC | *W EXP 10/27/202 | G8059B119 | 10,144 | 101,439 | SH | SOLE | 101,439 | 0 | 0 | |||
SILK RD MED INC | COM | 82710M100 | 1,760,850 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | |||
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 8,223 | 82,233 | SH | SOLE | 82,233 | 0 | 0 | |||
TC BIOPHARM HOLDINGS PLC | *W EXP 02/08/202 | 87807D111 | 1,880 | 18,823 | SH | SOLE | 18,823 | 0 | 0 | |||
TG VENTURE ACQUISITION CORP | *W EXP 08/15/202 | 87251T117 | 9,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
TG VENTURE ACQUISITION CORP | CLASS A COM | 87251T109 | 2,070,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 1,000,012 | 112,614 | SH | SOLE | 112,614 | 0 | 0 | |||
VAREX IMAGING CORP | COM | 92214X106 | 3,001,350 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | |||
VAXCYTE INC | COM | 92243G108 | 1,611,640 | 43,000 | SH | SOLE | 43,000 | 0 | 0 | |||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 1,842,500 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | |||
VERA THERAPEUTICS INC | CL A | 92337R101 | 2,219,360 | 286,000 | SH | SOLE | 286,000 | 0 | 0 | |||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 502,000 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | |||
WEARABLE DEVICES LTD | *W EXP 09/14/202 | M97838110 | 193,672 | 1,411,600 | SH | SOLE | 1,411,600 | 0 | 0 | |||
WESTERN ACQSTN VENTURES CORP | *W EXP 09/01/202 | 95758L115 | 8,900 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
WESTERN ACQSTN VENTURES CORP | COM | 95758L107 | 1,021,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
XTANT MED HLDGS INC | COM NEW | 98420P308 | 3,970,069 | 6,227,559 | SH | SOLE | 6,227,559 | 0 | 0 |